Annual report pursuant to Section 13 and 15(d)

Stock Compensation Plans

v3.8.0.1
Stock Compensation Plans
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Compensation Plans
Stock Compensation Plans

Employee Stock Purchase Plan

Under the Company’s amended and restated Qualified Employee Stock Purchase Plan, a total of 10,000,000 shares of common stock are available for issuance. As currently administered by the Company’s compensation committee, all full-time employees may use a portion of their salary to acquire shares of LTS common stock under this purchase plan at a 5% discount from the market price of LTS’ common stock at the end of each option period. Option periods have been set at three month periods and commence on January 1, April 1, July 1 and October 1 of each year and end on March 31, June 30, September 30 and December 31 of each year. The plan is intended to qualify as an “employee stock purchase plan” under Section 423 of the Internal Revenue Code. During 2017, 167,016 shares of LTS common stock were issued to employees under this plan, at prices ranging from $2.32 to $3.00; during 2016, 210,330 shares of LTS common stock were issued to employees under this plan, at prices ranging from $2.19 to $2.38; and during 2015, 192,978 shares of LTS common stock were issued to employees under this plan, at prices ranging from $2.00 to $3.67. These share issuances resulted in a capital contribution of $420, $481 and $545 for 2017, 2016 and 2015, respectively.

Amended and Restated 1999 Performance Equity Plan and 2009 Incentive Compensation Plan

In 1999, the Company adopted the 1999 Performance Equity Plan (as amended and restated, the “1999 Plan”) and in 2009 the Company adopted the 2009 Incentive Compensation Plan (the “2009 Plan”), which provide for the grant of stock options and other awards to designated employees, officers and directors and certain other persons performing services for the Company and its subsidiaries, as designated by the board of directors. The 1999 Plan provides for the granting of up to 25,000,000 awards with an annual limit on grants to any individual of 1,500,000. In 2014, the 2009 Plan was amended to provide for the granting of up to 45,000,000 awards with an annual limit on grants to any individual of 1,500,000. Awards under the plans include stock options, stock appreciation rights, restricted stock, deferred stock, stock reload options and/or other stock-based awards. The compensation committee of the Company’s board of directors administers the plans. Stock options granted under the 2009 Plan may be incentive stock options and non-qualified stock options. An incentive stock option may be granted only through August 27, 2019 under the 2009 Plan and may only be exercised within ten years of the date of grant (or five years in the case of an incentive stock option granted to an optionee who at the time of the grant possesses more than 10% of the total combined voting power of all classes of stock of LTS (“10% Shareholder”)). Incentive stock options may no longer be granted under the 1999 Plan. The exercise price of both incentive and non-qualified options may not be less than 100% of the fair market value of LTS’ common stock at the date of grant, provided that the exercise price of an incentive stock option granted to a 10% Shareholder shall not be less than 110% of the fair market value of LTS’ common stock at the date of grant. As of December 31, 2017, 16,317,111 and 4,286,114 shares of common stock were available for issuance under the 2009 Plan and the 1999 Plan, respectively.

A summary of the status of the 1999 Plan at December 31, 2017 and changes during the year ended December 31, 2017 are presented below:

 
 
Shares
 
Weighted- Average Exercise Price
 
Weighted- Average Remaining Contractual Term (Years)
 
Aggregate Intrinsic Value
Options outstanding, December 31, 2016
 
12,122,500

 
$
1.62

 
 
 
 
Exercised
 
(3,300,500
)
 
2.25

 
 
 
 
Forfeited
 
(10,000
)
 
2.30

 
 
 
 
Expired
 
(180,000
)
 
2.63

 
 
 
 
Options outstanding, December 31, 2017
 
8,632,000

 
$
1.36

 
1.87
 
$
15,556

Options exercisable, December 31, 2017
 
8,632,000

 
$
1.36

 
1.87
 
$
15,556



A summary of the status of the 2009 Plan at December 31, 2017 and changes during the year ended December 31, 2017 are presented below:

 
 
Shares
 
Weighted- Average Exercise Price
 
Weighted- Average Remaining Contractual Term (Years)
 
Aggregate Intrinsic Value
Options outstanding, December 31, 2016
 
21,836,053

 
$
2.24

 
 
 
 
Exercised
 
(1,076,166
)
 
1.61

 
 
 
 
Forfeited
 
(271,026
)
 
2.34

 
  
 
  

Options outstanding, December 31, 2017
 
20,488,861

 
$
2.28

 
4.93
 
$
20,033

Options exercisable, December 31, 2017
 
18,344,361

 
$
2.15

 
4.68
 
$
19,672



Non-Plan Options

The Company has granted stock options to newly-hired employees in conjunction with their employment agreements or in connection with acquisitions, which are outside of the option plans. A summary of the status of these options at December 31, 2017 and changes during the year ended December 31, 2017 are presented below:
 
 
Shares
 
Weighted- Average Exercise Price
 
Weighted- Average Remaining Contractual Term (Years)
 
Aggregate Intrinsic Value
Options outstanding, December 31, 2016
 
3,000,000

 
$
1.91

 
 
 
 
Forfeited
 
(3,000,000
)
 
$
1.91

 
 
 
 
Options outstanding, December 31, 2017
 

 
$

 

 
$



The Company did not grant any options to employees or directors in 2017. The weighted-average grant date fair value of employee and director options granted during the years ended December 31, 2016 and 2015 was $1.07 and $2.79, respectively. The fair value of each option award was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted-average assumptions:

 
 
 
  
 
2016
 
2015
Dividend yield
 
%
 
%
Expected volatility
 
50.38
%
 
61.10
%
Risk-free interest rate
 
1.67
%
 
1.63
%
Expected life (in years)
 
6.11

 
6.15



The weighted average expected life for the 2016 and 2015 grants to employees and directors reflects the alternative simplified method permitted by authoritative guidance, which defines the expected life as the average of the contractual term of the options and the weighted-average vesting period for all option tranches. The Company estimates the expected term for stock options awarded to independent financial advisors using the contractual term. Expected volatility for the 2016 and 2015 option grants is based on the historical volatility of the common stock of the Company over the same number of years as the expected life, prior to the option grant date.

Restricted Stock Awards

A summary of the restricted stock awards at December 31, 2017 and changes during the year ended December 31, 2017 is presented below:

 
 
Restricted Stock
 
Weighted-Average Grant Date Fair Value Per Share
Nonvested at December 31, 2016
 
2,233,219

 
$
2.92

Issued during 2017
 
1,791,000

 
2.35

Vested during 2017
 
(639,073
)
 
3.04

Forfeited during 2017
 
(5,000
)
 
2.24

Nonvested at December 31, 2017
 
3,380,146

 
$
2.60



Restricted stock awards issued in 2017 vest in four equal annual installments.

As of December 31, 2017, there was $7,371 of total unrecognized compensation cost related to non-vested share-based compensation arrangements. This cost is expected to be recognized over the vesting periods of the options and restricted stock, which on a weighted-average basis is approximately 2.09 years.

The total intrinsic value of options exercised during the years ended December 31, 2017, 2016 and 2015 amounted to $3,992, $6,556 and $2,595, respectively. The fair value of restricted stock vesting in 2017 and 2016 was $1,944 and $1,197, respectively.

Non-cash compensation expense relating to stock options was calculated using the Black-Scholes option pricing model, amortizing the value calculated over the vesting period. The Company has elected to recognize compensation cost for option awards that have graded vesting schedules on a straight line basis over the requisite service period for the entire award.

For the years ended December 31, 2017, 2016 and 2015, non-cash compensation expense relating to share-based awards granted to employees, consultants and advisors amounted to $5,539, $5,311 and $8,759, respectively.